‘Good’ cholesterol drug may help diabetics
A drug designed to improve levels of `good` cholesterol may also help control blood sugar in diabetics who are on cholesterol-lowering drugs.
Researchers stumbled on this finding while analysing data from a clinical trial on the drug torcetrapib. The development of this drug was halted five years ago.
Torcetrapib is a cholesterol ester transfer protein (CETP) inhibitor, a type of drug that increases levels of high-density lipoproteins (HDLs, or `good` cholesterol), Journal of the American Heart Association.
The study found that 6,661 people with type 2 diabetes – also known as `adult-onset` diabetes – showed improved blood sugar control when taking torcetrapib along with a statin medication that reduces low-density lipoproteins (LDLs or `bad` cholesterol).
The inhibitor drugs may not only reduce the risk of heart attack and stroke, but may also improve the control of blood sugar in people with diabetes.